Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Journal of the Chinese Medical Association : JCMA|December 4, 2020
Precipitating factors causing hyperbilirubinemia during chronic hepatitis C treatment with paritaprevir/ritonavir/ombitasvir and dasabuvirYi-Kai Wang, Wei-Ping Lee, Ying-Wen Wang, et al.Cellular Signalling|July 20, 2011
Akt phosphorylation at Thr308 and Ser473 is required for CHIP-mediated ubiquitination of the kinaseChih-Hao Su, Cheng-Yi Wang, Keng-Hsin Lan, et al.Journal of Viral Hepatitis|August 21, 2018
Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapyI-Cheng Lee, Yee Chao, Chung-Pin Li, et al.International Journal of Molecular Sciences|October 14, 2022
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing ChemotherapyI-Cheng Lee, Keng-Hsin Lan, Chien-Wei Su, et al.Carcinogenesis|July 6, 2013
Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic modelHung-Chuan Pan, De-Wei Lai, Keng-Hsin Lan, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 19, 2020
Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis BI-Cheng Lee, Chien-Wei Su, Keng-Hsin Lan, et al.Scientific Reports|June 15, 2022
Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterolYi-Kai Wang, Ying-Wen Wang, Chia-Ling Lu, et al.Journal of Hepatology|February 27, 2009
Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modificationYi-Hsiang Huang, Jaw-Ching Wu, Wei-Li Peng, et al.Journal of Clinical Gastroenterology|July 21, 2017
Same-day Versus Split-dose Bowel Preparation Before Colonoscopy: A Meta-analysisYuan-Lung Cheng, Kuang-Wei Huang, Wei-Chih Liao, et al.Cancers|January 17, 2020
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular CarcinomaPei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.Pageof 6